Michelle Monje, MD, PHD
Chairperson
PEDIATRIC NEURO ONCOLOGY
LUCILE PACKARD CHILDREN’S HOSPITAL
Michelle Monje, MD, PhD, is a pediatric neuro-oncologist, a professor of Neurology and Neurological Sciences and a Howard Hughes Medical Institute Investigator at Stanford University. Her research program focuses on DIPG and other diffuse midline gliomas at the intersection of neuroscience, immunology and brain cancer biology. Dr. Monje has led several of her discoveries from basic molecular work to clinical trials. She has been recognized with numerous honors, including an NIH Director’s Pioneer Award, a MacArthur Fellowship and election to the National Academy of Medicine.
Carl Koschmann, MD
PEDIATRIC NEURO ONCOLOGY
CS MOTT CHILDREN’S HOSPITAL
Dr. Carl Koschmann is a pediatric neuro-oncologist and the Clinical Scientific Director of the University of Michigan Chad Carr Pediatric Brain Tumor Center, and cares for children and young adults with brain tumors. He specializes in the research and treatment of high-risk brain tumors, including high-grade glioma, diffuse midline glioma (DMG), and diffuse intrinsic pontine glioma (DIPG). His NIH-funded laboratory explores mechanisms by which mutations in these tumors drive their formation and impact treatment response.
Dr. Koschmann also serves as the Co-Scientific Chair of the Children’s Brain Tumor Network, which is the largest pediatric brain tumor data and sample repository. He is the PI/Co-PI for multiple early phase studies in pHGG/DMG for which his lab performs analysis of correlate tumor and spinal fluid samples.